Advertisement

Search Results for "Visicu Inc Andover Ma"

00:06 EDT 24th May 2013 | BioPortfolio

Original Source: Philips VISICU

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a diversified Health and Well-being company, focused on improving people's lives through timely innovations. As a world leader in healthcare, lifestyle and lighting, Philips integrates technologies and design into people-centric solutions, based on fundamental customer insights and the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs more than 118,000 employees in more than 60 countries worldwide....

Matching Channels

None

Matching News

Sonesta Announces New Extended Stay Hotel in Andover, MA: Sonesta ES Suites Andover

BOSTON, May 29, 2012 (GLOBE NEWSWIRE) -- Sonesta International Hotels Corporation today announced a new extended stay hotel, the 133-room Sonesta ES Suites Andover. Scheduled to come under Sonesta ma...

Navidea Biopharmaceuticals opens new facility in Andover, Mass.

Navidea Biopharmaceuticals, a Dublin, Ohio-based specialty biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has opened its new business and commercialization facility in...

Sonesta ES Suites Begins Operations in Andover, MA

BOSTON, July 25, 2012 (GLOBE NEWSWIRE) -- Sonesta begins operation today at the 133-room Sonesta ES Suites Andover. Reservations are available by calling +1.617.315.9100; toll free +1.800.SONESTA or...

Integra LifeSciences Receives Warning Letter in Andover, England Manufacturing Facility

PLAINSBORO, N.J., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that on November 5, 2012 it received a warning letter from the United State...

Well Respected Orthopaedic Practice Joins Dingmans’ Medical Community

Dingmans Ferry, PA, June 29, 2012 --(PR.com)-- Andover Orthopaedic Surgery & Sports Medicine Group, a welcomed addition to the Pike County medical community, is now seeing patients at their new o...

TransMedics, Inc.: Series E $36M

TransMedics (Andover, MA) a commercial-stage medical device company focused on organ preservation technologies for transplants, closed a $36M Series E financing. Participants include Abrams Capital, F...

Mass. firm worker accused of illegal China exports

A Chinese employee of a Massachusetts company has been charged in federal court with smuggling into China $6.5 million worth of equipment that can be used to enrich and produce weapons-grade uranium....

NaviSite Bought By Time Warner, BG Medicine Goes Public, Omnicom Gets Communispace, & More Boston-Area Deals News

Startup financings and acquisitions news have poured into the New England area at roughly the same rate the precipitation has in the last week. —Andover, MA-based IT services provider NaviSite w...

Matching PubMed Articles

Concerns regarding sinking of South Korean warship.

In Vitro Screening of Metabolic Clearance Using Two Concentration Points.

For high throughput screens, the quickest methodology possible is desirable, but a substantial amount of potentially useful information is lacking since most screens for metabolic stability are conduc...

Interactions between the chemotherapeutic agent eribulin mesylate (E7389) and P-glycoprotein in CF-1 abcb1a-deficient mice and Caco-2 cells.

Eribulin is a new anticancer agent currently in Phase III clinical trials for the treatment of metastatic breast cancer. In the current studies, we have investigated the effects of P-glycoprotein (P-g...

Development of a multiplex UPLC-MRM MS method for quantification of human membrane transport proteins OATP1B1, OATP1B3 and OATP2B1 in in vitro systems and tissues.

OATP1B1, OATP1B3 and OATP2B1 are important members of the organic anion transporting polypeptides (OATP) family and are implicated in the hepatic disposition of endobiotics and xenobiotics. Quantitati...

The safety and efficacy of alcaftadine 0.25% ophthalmic solution for the prevention of itching associated with allergic conjunctivitis.

Abstract Objective: The purpose of this study was to evaluate the safety and clinical efficacy of alcaftadine 0.25% ophthalmic solution, a new topical anti-allergic agent for the prevention of the sig...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement